🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Eric T. Roberts

University of California, San Francisco

ORCID: 0009-0005-8435-8994

Also affiliated with Oral Roberts University

Economics, Econometrics and FinanceMedicinePhysics and AstronomyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.497Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Patterns of Infliximab Biosimilar Uptake for Medicare, Medicaid, and Private Insurance from 2016 to 2022

Arthritis & Rheumatology(2024)10.1002/art.42963
Top 39%
0.497DataRank
Top 39%7 citations

Jing Li, Nick Bansback, Chien‐Wen Tseng, Steve Shiboski, Gabriela Schmajuk +2 more

Papers

Driven by 8 papers — median percentile 61. Top paper: “Patterns of Infliximab Biosimilar Uptake for Medicare, Medicaid, and Private Insurance from 2016 to 2022”.

Patterns of Infliximab Biosimilar Uptake for Medicare, Medicaid, and Private Insurance from 2016 to 2022

Arthritis & Rheumatology(2024)10.1002/art.42963
Top 39%
0.497DataRank
Top 39%7 citations

Jing Li, Nick Bansback, Chien‐Wen Tseng, Steve Shiboski, Gabriela Schmajuk +2 more

Nationwide Availability of and Enrollment in Medicare and Medicaid Dual-Eligible Special Needs Plans With Exclusively Aligned Enrollment

JAMA Health Forum(2024)10.1001/jamahealthforum.2024.3546
N/A
0.269DataRank · unranked
5 citations

Michelle A. Hendricks, Megha Dabas, Eliza Macneal, Jeah Jung, David J. Meyers +3 more

Sex Differences in Medication Discontinuation in Axial Spondyloarthritis

Arthritis Care & Research(2025)10.1002/acr.70001
N/A
0.104DataRank · unranked
1 citations

Cinthia Blat, Eric T. Roberts, Jean W. Liew, Katherine D. Wysham, Namrata Singh +5 more

Reply

Arthritis Care & Research(2025)10.1002/acr.25533
N/A
0.104DataRank · unranked
1 citations

Matthew Murrill, Gabriela Schmajuk, Jinoos Yazdany, Eric T. Roberts

Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures

medRxiv(2025)10.1101/2025.07.25.25332013
N/A
0DataRank · unranked
0 citations

Gustavo E. Velásquez, John D. Szumowski, Allison L. Phillips, Annie Kim, Jinoos Yazdany +8 more

Tuberculosis Infection Screening Recommendations for Targeted Immunotherapies: Comparison of US Prescribing Information, Clinical Resources, and Quality Measures

Clinical Infectious Diseases(2025)10.1093/cid/ciaf628
N/A
0DataRank · unranked
1 citations

Gustavo E. Velásquez, John D. Szumowski, Allison L. Phillips, Annie Kim, Jinoos Yazdany +8 more

Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus

The Journal of Rheumatology(2025)10.3899/jrheum.2024-0961
N/A
0DataRank · unranked
0 citations

Eric T. Roberts, Courtney Hoge, Brad D. Pearce, C. Barrett Bowling, Laura Plantinga

Latent Tuberculosis Screening Among New Users of a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug: Gaps in Screening Overall and Among Janus Kinase Inhibitors

Arthritis Care & Research(2024)10.1002/acr.25318
N/A
0DataRank · unranked
7 citations

Gabriela Schmajuk, Jing Li, Matthew Murrill, Jinoos Yazdany, Eric T. Roberts